Simotinib Hydrochloride

盐酸西莫替尼

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameSimotinib Hydrochloride
Drug Alias NameXimotiniSIM-6802AL-6802
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesJiangsu Simcere Pharmaceutical Co LtdAdvenchen Laboratories Llc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJiangsu Xiansheng Medicament Research Co LtdNanjing Simcere Dongyuan Pharmaceutical Co Ltd
Inactive CompaniesJiangsu Simcere Pharmaceutical Co Ltd
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A